Updates
** Shares of drugmaker Liquidia Corp LQDA.O rise 8.7% to $45.99
** Co swings to Q1 net profit of 52 cents per share compared to a net loss of 45 cents per share a year ago
** Reports Q1 revenue of $132.9 million beating estimates of $116.68 million - as per LSEG-compiled data
** Reports Q1 sales of its hypertension drug Yutrepia of $129.9 million vs no product sales a year ago
** Co says about 3,750 patients started treatment since launch in June 2025
** Cash and cash equivalents totaled $222.8 million as of March 31, 2026, compared to $190.7 million as of December 31
** Including session moves, stock up 22.5% YTD
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com;))